Archive for August, 2020

$WTER 420 with CNW – Federal Report Shows Legalization Hasn’t Increased Youth Marijuana Use

A report from the CDC shows that cannabis consumption among teens has decreased during the years after states legalized recreational marijuana use.

According to the biannual Youth Risk Behavior Survey that was released on Friday, cannabis consumption increased between 2009 and 2013 then declined between 2013 and 2019. The data thus supports the case from backers that asserted that the creation of a regulated cannabis market would not influence youth consumption as prohibitionists had previously warned.

The survey also found that the rate of marijuana use recorded no change among teens and high school students between 2009 and 2019 despite consumption methods diversifying. When the analysis was done using another method, cannabis consumption declined during the 2009-2019 period.

The results confirmed the need to carry on the promotion of cannabis legalization and the regulation of community safety benefits as well as public health and with focus on limiting youth access.

The CDC report also shows 21.7 % of students in high school admitted to consuming cannabis in the last 30 days, while 29.2% reported to have consumed alcohol in the same period window. For lifetime use however, marijuana consumption is represented at 36.8%/

SAM, a prohibitionist group, stated that the data was a legalization negative. This is in spite of the figures showing that marijuana use hasn’t grown among teens with more states legalizing its use.

However, the analysis does not account for the fact that the CDC failed to include and observe lifetime alcohol use at any stage and the data was excluded from the report in 2019. The reason for this being that Youth Risk Behavior Survey coordinators decided to not include the question, this is including other changes that were made to the questions for the survey in the year 2018. However, no specific reason was given as to why the members decided to make the decision to do so.

In comparison though, alcohol use surpassed marijuana use. Therefore, making the assumption that trends of consumption would be the same is not far-fetched.

According to previous studies that focused on rates of teen use after cannabis legalization, there was a clear decrease in consumption. However, a related absence of evidence indicates an increase.

For instance, a study that collected data from the State of Washington ascertained that the decline in consumption of cannabis might be explained by the regulations that replaced the illegal market, which made marijuana lose its appeal.

This research is likely to come as good news to cannabis industry players like The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) who felt it was wrong to say marijuana legalization would increase teen use of the substance.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Monday, August 31st, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Federal Report Shows Legalization Hasn’t Increased Youth Marijuana Use

$GNPX Why Healthcare Professionals Should Utilize Social Media

As you join medical school, one of the first things that you will undergo during the orientation period is watching instructional videos. The videos are always about social media and what you should do and what you should not do as an upcoming healthcare professional. For long periods now, healthcare worker, were advised against the use of social media, especially when at work.

As a physician, there are some things that you are not supposed to do at all costs. For instance, you are not supposed to post the patients’ personal information, expose medically vital information, and disclose the patient’s image without their permission. However, social media does have a place in the life of a medical worker.

The use of social media is becoming an important tool that you should start familiarizing yourself with as a health worker. Several things that are found on social media are exciting and amazing that you, as a physician, can use to help your patients.

A good number of patients share their stories and create awareness of what they have gone through during their sickness. Furthermore, some patients who have recovered have formed community-based groups to help those patients who are having it rough. The groups are inspiring and motivating people, and you as a physician should also not be left out.

Initially, you may have seen social media platforms as areas where people can only throw their pictures having fun and going on trips. Things have now changed; today you will find live interviews, question and answer live videos for students, individuals talking of their difficult moments and how they managed, and more so the social impact organizations. Several people are now using social media arenas to collaborate with others, encourage those who are low and also make other noticeable progress.

Since most of the healthcare professionals have a busy schedule, using social media may be a challenge to them. However, you can create your own time as a physician and use the platform to make an impact in the lives of others. You can use social media to spread a message of hope to some of your patients who are almost giving up.

Medical institutions should start teaching their students how they can use social media in a more positive way. As you can see, social media is gaining popularity day in and day out, and medical schools need to take advantage of this. It is the moment medical schools must join the trails and highlight to their students the essence of incorporating social media while impacting the lives of patients.

They should teach their students from the start of what to do instead of focusing alone on what should not be done using social media. You may never know what benefits social media will bring, but we can assure you it will positively impact the lives of millions of people. You can also link with other physicians in different locations and learn new things about medicine and its various uses. This will help you gain more information as a physician, and you will significantly help your patients. A look at the social media presence of companies like Genprex Inc. (NASDAQ: GNPX) shows how important social media can be in all walks of life.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, August 31st, 2020 Uncategorized Comments Off on $GNPX Why Healthcare Professionals Should Utilize Social Media

$GNPX $WRTC $MEDS $SRAX $SGLB $UUUU $POAI LD Micro – 360 Companies Set to Present – this Week

LOS ANGELES, CA / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Registration details and the company schedule can be seen here: https://ld500.ldmicro.com

“I have slept well since March,” said Chris Lahiji, Founder of LD Micro.

The list of presenters in below:

1847 Goedeker GOED
1847 Holdings LLC EFSH
22nd Century Group, Inc. XXII
AcelRx Pharmaceuticals, Inc. ACRX
Acer Therapeutics ACER
Acme United Corp ACU
Actinium Pharmaceuticals, Inc. ATNM
AcuityAds AT.TO
ADDvantage Technologies Group, Inc. AEY
Adial Pharmaceuticals Inc. ADIL
Aditxt Therapeutics ADTX
Advaxis ADXS
Aehr Test Systems AEHR
AIkido Pharma Inc. AIKI
AIM ImmunoTech Inc. AIM
Air Industries Group AIRI
Akerna KERN
Alfi Inc. PRIVATE
Algernon Pharmaceuticals AGNPF
Alimera Sciences ALIM
ALJ Regional Holdings ALJJ
Allot ALLT
Alpine 4 Technologies ALPP
Altigen Communications ATGN
American Resources Inc. AREC
American Shared Hospital Services AMS
AnalytixInsight Inc. ALY
Annovis Bio ANVS
Antibe Therapeutics ATE.V
Apollo Endosurgery, Inc. APEN
Applied Energetics, Inc. AERG
Aptorum Group Limited APM
Aqua Metals AQMS
AquaBounty Technologies AQB
Arch Therapeutics ARTH
Arcimoto FUV
Arcturus Therapeutics ARCT
Artelo Biosciences, Inc. ARTL
Assure Holdings ARHH
Asure Software ASUR
Atomera Incorporated ATOM
Atossa Therapeutics, Inc. ATOS
AutoWeb, Inc. AUTO
Avivagen VIVXF
Axos Financial AX
AYRO Inc AYRO
AzurRx BioPharma, Inc. AZRX
Ballantyne Strong Inc BTN
Barfresh Food Group BRFH
Bel Fuse, Inc. BELFA
BELLUS Health BLU
BIO-key International BKYI
BioCardia, Inc. BCDA
Biocept, Inc. BIOC
Bioceres Crop Solution BIOX
BioHiTech Global BHTG
BioLargo, Inc. BLGO
Biolase, Inc. BIOL
Biomerica BMRA
BioSig Technologies BSGM
BioSyent Inc. RX.V
BK Technologies BKTI
BlackBoxStocks, Inc. BLBX
Blink Charging BLNK
BlueCity BLCT
Blueknight BKEP
Boxlight Corporation BOXL
Bridgeline BLIN
Bright Mountain Media BMTM
C-Bond Systems CBNT
Caladrius Biosciences CLBS
Calmare Therapeutics CTTC
Calyxt, Inc. CLXT
Camtek Ltd. CAMT
Can B Corp. CANB
Can-Fite BioPharma, Ltd. CANF
Capricor Therapeutics CAPR
Capstone Turbine CPST
CEL-SCI Corporation CVM
Celsius Holdings, Inc. CELH
CEMATRIX Corporation CVX.V
Cemtrex, Inc. CETX
Chicken Soup for the Soul Entertainment CSSE
ChromaDex CDXC
Citius Pharmaceuticals, Inc. CTXR
Cleanspark CLSK
ClearOne Communications Inc. CLRO
CloudMD Software DOCRF
CLPS Incorporation CLPS
Compass Diversified Holdings CODI
Converge Technology Solutions CTS
Conversion Labs CVLB
Crown EK CRKN
CTG CTG
Cure Pharmaceutical CURR
CynergisTek, Inc. CTEK
Cytosorbents Corporation CTSO
Data443 Risk Mitigation ATDS
Delcath Systems Inc. DCTH
Diginex JFK
Digirad Corporation DRAD
Digital Ally DGLY
Dolphin Entertainment Inc. DLPN
DPW Holdings, Inc. DPW
Driven Deliveries, Inc. DRVD
Dyadic International, Inc. DYAI
Edesa Biotech, Inc. EDSA
ElectraMeccanica Vehicles Corp. SOLO
electroCore ECOR
eMagin EMAN
ENDRA Life Sciences Inc. NDRA
Energous WATT
Energy Focus, Inc. EFOI
Energy Fuels UUUU
Enthusiast Gaming EGLX
EnviroLeach Technologies Inc. EVLLF
Envision Solar EVSI
Esports Entertainment Group GMBL
Evogene EVGN
Excellon Resources EXLLF
Exro Technologies Inc XRO
FAT Brands Inc. FAT
FinCanna Capital CALI.CN
Flux Power Holdings FLUX
Foresight Autonomous Holdings Ltd. FRSX
Fortress Biotech FBIO
Freedom Holding Corp. FRHC
Futuris MISM
Genasys Inc. GNSS
Genprex, Inc. GNPX
Gigatronics GIGA
Global Crossing Airlines JETMF
Global Self Storage SELF
Goldmoney Inc. XAUMF
GOLO Mobile Inc. GOLO
Greenbox POS GRBX
Greenbrook TMS NeuroHealth Centers GTMS
Grom Social Enterprises GRMM
GSI Technology GSIT
HealthWarehouse.com, Inc. HEWA
Helius Medical Technologies HSDT
Heritage Global, Inc. HGBL
Heritage Insurance Holdings, Inc. HRTG
Hill Street Beverage Company Ltd. BEER.V
Hoth Therapeutics, Inc HOTH
Humanigen, Inc. HGEN
iCAD ICAD
iConsumer Corp RWRDP
Ideal Power IPWR
Ideanomics IDEX
IDEAYA Biosciences IDYA
IDW Media IDWM
IEC Electronics IEC
IMAC Holdings IMAC
ImmunoPrecise Antibodies IPATF
Immunovia AB IMMNOV
IMV Inc. IMV
Indonesia Energy Corporation INDO
InfuSystems INFU
Innovative Food Holdings IVFH
Inpixon INPX
InspireMD NSPR
Intellicheck, Inc. IDN
Interlink Electronics LINK
inTEST Corporation INTT
Inuvo, Inc. INUV
Issuer Direct Corporation ISDR
JanOne Inc. JAN
Jerash Holdings JRSH
Kandi Technologies KNDI
Killi Ltd. MYID
Kindred Biosciences KIN
Kintara Therapeutics, Inc. KTRA
Know Labs, Inc. KNWN
Kontrol Energy Corp. KNRLF
KULR Technology Group KULR
Lantern Pharma LTRN
Leatt Corporation LEAT
Lexaria Bioscience LXRP
LifeQuest World Corporation LQWC
LifeVantage LFVN
LightPath Technologies LPTH
Lightwave Logic LWLG
Limbach Holdings, Inc. LMB
Lineage Cell Therapeutics, Inc. LCTX
LiveXLive Media, Inc. LIVX
Lomiko Metals Inc. LMRMF
Mace Security International, Inc. MACE
Magal Security Systems Ltd. MAGS
Mako Mining MAKOF
Mama Mancini’s MMMB
Manitex International Inc MNTX
Marrone Bio Innovations MBII
Matinas MTNB
Medallion Financial Corp. MFIN
Medexus Pharmaceuticals Inc. MDP.V
Mene MENE
Meritage Hospitality Group MHGU
Microbix Biosystems Inc. MBX.TO
Microbot Medical MBOT
Milestone Scientific MLSS
Mohawk Group MWK
Moleculin Biotech MBRX
Monaker Group MKGI
MTBC, Inc. MTBC
My Size Inc. MYSZ
Myomo MYO
NameSilo Technologies URL.CN
Nanalysis Corp. NSCI
Nano Dimension NNDM
Nanotech Security Corp. NTS.V
NanoViricides, Inc. NNVC
Navidea Biopharmaceuticals NAVB
nDivision Inc. NDVN
Nemaura Medical NMRD
NeoGenomics NEO
Nephros, Inc. NEPH
NervGen Pharma Corp. NGENF
Neubase Therapeutics, Inc. NBSE
Newtek Business Services NEWT
Newtopia NEWU
Nightfood Holdings NGTF
Nova Leap Health Corp. NLH.V
NowRx PRIVATE
NXT Energy Solutions NSFDF
Oblong Inc. OBLG
Ocugen, Inc. OCGN
Odyssey Group International ODYY
Odyssey Marine Exploration OMEX
OMNIQ Corporation OMQS
OncoCyte Corporation OCX
Oncolytics Biotech, Inc. ONCY
OncoSec Medical Incorporated ONCS
One Stop Systems OSS
OneSoft Solutions Inc. OSS.V
OpGen OPGN
OpSens Inc. OPS
Optex Systems Holdings OPXS
OptimizeRx OPRX
Origin Agritech Limited SEED
Orion Energy Systems OESX
PAVmed Inc. PAVM
Pelican Delivers PRIVATE
Performant PFMT
PFSweb, Inc. PFSW
Piedmont Lithium PLL
Plus Therapeutics, Inc. PSTV
POET Technologies Inc PTK.V
Predictive Oncology Inc. POAI
Profire Energy PFIE
Protech Home Medical Corp. PTQQF
Quantum Computing Inc. QUBT
Quisitive Technology Solutions QUIS
Qumu Corporation QUMU
Ra Medical Systems RMED
RADA Electronic Industries Ltd RADA
Radcom Ltd. RDCM
RadNet, Inc. RDNT
Rafael Holdings RFL
Rainmaker ANY
RCI Hospitality Holdings, Inc. RICK
RedHill Biopharma RDHL
Redishred Capital Corp. KUT
Rekor Systems, Inc REKR
Remark Holdings MARK
Renesola Power SOL
Research Solutions RSSS
Resonant Inc. RESN
RIWI Corp. RIWI.V
RumbleOn RMBL
Safeguard Scientifics, Inc SFE
Salarius Pharmaceuticals SLRX
Sangoma Technologies STC.V
SANUWAVE SNWV
ShiftPixy PIXY
Sigma Labs, Inc. SGLB
Simulations Plus SLP
Slinger Bag SLBG
Smith-Midland Corporation SMID
Soligenix, Inc. SNGX
Sono-Tek SOTK
Sorrento Therapeutics SRNE
SRAX, Inc. SRAX
Stereotaxis STXS
Streamline Medical Group PRIVATE
Summit Wireless Technologies WISA
Sunworks Inc. SUNW
Super League Gaming, Inc. SLGG
Taronis Fuels TRNF
The Joint Chiropractic JYNT
The Singing Machine Company SMDM
Theralink Technologies OBMP
ThermoGenesis Holdings, Inc. THMO
Thunderbird Entertainment TBRD.V
Timber Pharmaceuticals TMBR
Tinybeans TNYYF
Titan Medical TMD
Tiziana Life Sciences PLC TLSA
Todos Medical LTD TOMDF
Tonix Pharmaceuticals TNXP
Torchlight Energy Resources, Inc. TRCH
Transphorm TGAN
Trxade Group MEDS
Turtle Beach Corporation HEAR
UGE International Ltd. UGE.V
Ur-Energy Inc. URG
US Gold Corp USAU
US Nuclear Corporation UCLE
Verb Technology VERB
VerifyMe VRME
Vertex Energy VTNR
Victory Square Technologies VST
Village Farms International VFF
VIQ Solutions VQS
VirTra, Inc. VTSI
Vision Marine Technologies, Inc. VMAR
VistaGen Therapeutics VTGN
Vivos Inc. RDGL
Volition RX Ltd VNRX
Vox Royalty VOX.V
Voyager Digital (Canada) Ltd VYGVF
Vuzix Corporation VUZI
WANdisco, Inc WANSF
Wayside Technology Group Inc WSTG
WeedMD WDDMF
WELL Health Technologies WELL.TO
Weyland Tech WEYL
WidePoint Corporation WYY
Willow Biosciences CANSF
Wireless Telecom Group WTT
Workhorse Group WKHS
Wrap Technologies WRTC
Xinyuan Real Estate XIN
Xpel Inc XPEL
Xtra-Gold Resources Corp. XTG
Yatra Online, Inc. YTRA
Yield10 Bioscience, Inc. YTEN
ZAGG Inc ZAGG
Zedge, Inc. ZDGE
Zoom Telephonics ZMTP
Zynex, Inc. ZYXI

About LD Micro:

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure micro-cap index (LDMi) which covers stocks in North America with market capitalizations between $50 million to $300 million.

Monday, August 31st, 2020 Uncategorized Comments Off on $GNPX $WRTC $MEDS $SRAX $SGLB $UUUU $POAI LD Micro – 360 Companies Set to Present – this Week

$WRTC to Present to Live Virtual Audience at The LD 500

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its plans to present at the LD 500 investor conference, scheduled to take place from Sept. 1-4, 2020. According to the update, Wrap Technologies’ management will be presenting to a live virtual audience at 10:40 a.m. PT / 1:40 p.m. ET. on Thursday, Sept. 3, and holding one-on-one virtual meetings with institutional investors and analysts throughout the day. The presentation will be webcast live and made available for replay by visiting http://nnw.fm/mGXWx, with a replay of the presentation also available on the company’s website. Interested parties may register for the event via the following link: http://nnw.fm/cqddv.

To view the full press release, visit: http://nnw.fm/SCi3W

About Wrap Technologies, Inc.

Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury by agencies in cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth and Oak Ridge. For information about the company, please visit www.WrapTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Friday, August 28th, 2020 Uncategorized Comments Off on $WRTC to Present to Live Virtual Audience at The LD 500

$MEDS Augments B2B Services with New Bundled, COVID-responsive Employee Wellness Package

  • Pharmaceutical supplies and services innovator Trxade Group Inc. has announced a new B2B resource that bundles telemedicine services that may prove particularly useful for companies during the ongoing pandemic period
  • Trxade Group’s new Bonum+ platform combines the power of telehealth consultation, AI-driven COVID-19 risk assessment and streamlined personal protective equipment purchasing to help manage employees’ care and performance
  • The company is an emerging web-based presence in the wellness market that builds trust and independent pharmacy purchasing power through drug pricing transparency
  • The company has achieved more than 50 percent penetration among the nation’s approximately 22,000 independent pharmacies.

Trxade Group (NASDAQ: MEDS) is expanding the B2B functionality of its supply chain trading platform through a first-of-its-kind bundled service that combines telehealth performance, a COVID-19 risk assessment tool and a personal protective equipment (“PPE”) purchasing tool to help businesses better deal with the medical needs of their internal corporate structures during an era of pandemic and beyond.

The company’s Bonum+ platform (http://nnw.fm/05X5O) builds on the Bonum Health Hub wellness brand that has established a web-accessible medical consultation service in conjunction with an online prescription pharmaceutical presence (http://nnw.fm/vBxt6) and the company’s app-accessible DelivMeds same-day / mail order pharmaceuticals delivery service (http://nnw.fm/YTRRS).

“This platform resolves a fundamental trust problem impacting employer’s safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace,” Bonum Health President Ashton Maaraba stated in the company’s most recent announcement. “Looking forward, we plan to continue to expand the breadth of services offered by Bonum Health, including adding a digital health hub with next-generation prescription concierge services.”

The Bonum+ platform centralizes communication and provides tools for COVID-19 contact tracing that helps companies assess employee risk profiles and respond as necessary with new PPE resources. The platform also offers health recommendations and connects employees with board certified physicians when needed, utilizing integrated artificial intelligence to streamline processes.

Trxade Group has distinguished itself as a web-based presence in the wellness market that emphasizes transparency in the pharmaceutical purchasing pipeline, empowering subscribers to assess drug prices and supply availability to make best product ordering decisions.

The company’s flagship platform has achieved more than 50 percent market penetration in attracting nearly 12,000 of the United States’ estimated 22,000 independent pharmacies so far, helping them to become more competitive with large pharmaceutical retail chains.

“Our platform lets these independents know that they’re receiving a fair price from competing suppliers on fair payment terms and often with next day delivery,” Founder, Chairman and CEO Suren Ajjarapu said in a recent earnings conference call (http://nnw.fm/exAAa). “We believe this radical price transparency, economy of scale and competition amongst suppliers leads (to) up to 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products.”

Trxade Group thereby saves pharmacists from labor-intensive cost comparisons between pharmaceutical distributors on a repetitive basis, profiting through a fee structure similar in nature to the ones employed by merchandising pioneers such as PayPal and Visa.

The company’s second quarter financial report notes that revenues increased 244 percent year-over-year for the quarter, and by 199 percent sequentially from the first quarter of the year.

“We believe that we are well positioned to execute upon the immense opportunity facing us today, supporting critical public health efforts nationwide,” Maaraba stated.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, August 28th, 2020 Uncategorized Comments Off on $MEDS Augments B2B Services with New Bundled, COVID-responsive Employee Wellness Package

$POAI Maximizing the Value of Drug Patents Before Losing Exclusivity

When you lose your drug patent exclusivity, it does not mean that you have lost your income when. Your anxiety may be awakened if only a new drug competitor enters the market. However, you can still ensure that your product still reaps big profits even if your drug patent is approaching loss of exclusivity. These are some of the ways you can maximize product value as a loss of exclusivity looms:

Early Planning

You should start developing your loss of exclusivity plans for your product at least two years before your drug patent expires. You can begin to implement this plan before you lose your exclusivity. If you wait till the last minute, you will minimize the efficiency of your efforts to build another drug brand relationship.

Venture into Over-the-Counter Drugs (“OTC”)

If you release an OTC drug into the market, it will allow you to access a broader range of customers. It will also lighten your concerns about your insurer repayment. However, you will incur some costs taking your OTC drugs to the market. These costs can be covered adequately and efficiently by the expanded and bigger market.

Create New Supply System

If you consider innovating how drugs are supplied, you will be able to keep the generic competition at a halt. For instance, antipsychotic drug developers came up with a longer-lasting version that has to be administered only four times annually. The merits in terms of patient conformity can make your branded drug to be adored over the generics that don’t offer a long-lasting solution for patients.

Stop Sales & Marketing

You may also decide to stop your sales and marketing activities but focus on adjusting your invention levels. Your medicines will remain in the market but without your previous sales and marketing strategies. This will allow you to reduce your expenditure but still maintaining your drug presence in the market. It is one of the best-liked loss of exclusivity plans in situations where there is a more significant competition from the generics and where competing with them directly is a problem.

Consider the Generic Market

Your drug company can create its own generic version of a drug that is about to face the loss of exclusivity in order to mitigate the adverse effects of losing patent exclusivity. There are different types of generics, and your company can opt for one that suits it:

  • Licensed generics- you enter a contract with a generic competitor to come up with the generic. Hence you also allow the generic competitor to enter the market earlier than expected.
  • Branded generics- You create a generic drug that is given its brand and sold at a lower price than the original brand.
  • Authorized generics- You provide a private licensed firm with a generic produced by your own company’s production facilities.

These are some of the strategies that you can adopt while you are facing drug patent expiration. It will also help you when you choose these strategies at the earliest time possible. Monitoring the market in case of any changes should also be one of your focus if you want to maximize your profits when you find yourself in this scenario. How do biomedical companies like Predictive Oncology (NASDAQ: POAI) handle this transition? One can only speculate!

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, August 28th, 2020 Uncategorized Comments Off on $POAI Maximizing the Value of Drug Patents Before Losing Exclusivity

$JMDAD Intends to Rebrand, Uplist to Nasdaq Capital Market

Jerrick Media Holdings (OTCQB: JMDAD) CEO Jeremy Frommer recently provided an update regarding the company’s stock and planned rebranding from Jerrick to Creatd. On August 17, 2020, Jerrick effectuated a 1-for-3 reverse stock split of its issued and outstanding shares of common stock (http://nnw.fm/OHkD6). Following the reverse split, the company’s common stock began trading on a split-adjusted basis under the temporary symbol “JMDAD” on the OTCMarkets. Upon the completion of Jerrick’s anticipated uplisting, the company will begin trading on the Nasdaq Capital Market under the new stock symbol “CRTD”.

For more information, visit the company’s website at www.Jerrick.media.

About Jerrick Media Holdings Inc.

Jerrick is the parent company and creator of the Vocal platform. The company creates technology-based solutions to solve problems for the creative community. Through Vocal, Jerrick identifies and leverages opportunities within the digital platform and content monetization space. Since launching in 2016, Vocal has become home to over 600,000 content creators and brands of all shapes and sizes, attracting audiences across its network of wholly owned and operated communities.

NOTE TO INVESTORS: The latest news and updates relating to JMDAD are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Friday, August 28th, 2020 Uncategorized Comments Off on $JMDAD Intends to Rebrand, Uplist to Nasdaq Capital Market

$DRIO Mistakes to Avoid When Planning a Drug Launch

Launching a new product is always a huge undertaking. Though your company has managed to enter the market on several occasions, not every moment will resemble or will be successful as other moments. As you launch your new drug into the market, several factors must be put in place to ensure that your drug launch is successful. Note that without following proper launching procedures, your entry into the market may fail.

Though mistakes are sometimes inevitable, you should try to avoid them during this important function. If your firm is gearing towards launching its novel drug or expanding into new markets, some of the mistakes to avoid for your launch to be successful are:

Excluding the Big Image

In any investment, it is always essential that you keep your eye on the big picture. In the drug industry, the bulk of things that you need to put in place for the drug launch to be successful can be a big load to you. You should therefore always put your primary focus on the main aspects of your drug launch and let other non-essential issues to be done behind the scenes.

However, you should also note that only focusing on main issues and ignoring other parts may greatly backfire. This is why you should go for a step-by-step procedure since focusing on the main image alone will imply that you follow a slow but thorough process. If you take a step-by-step approach, you will ensure all the stages are appropriately handled before you move to the next step.

Operating in The Vault

For you to achieve and have a successful launch of your novel drug into the market, working with all the parties concerned is essential. When you actively involve all the teams taking part in the launch of your project, you can be assured of an excellent product outcome. Keep all the communication avenues open to all the parties involved. There will be continuous sharing of vital insights and information, and this will help one team solve the other’s shortcomings in case one arises.

For instance, the team in charge of brand management in your firm can share their insights with the marketing team. In the pharmaceuticals, it is always essential that you keep communication rolling so that each member speaks the same narrative. The division of labor is still vital if you want to be successful, and it will help your product to gain milestones in the market for decades.

Insufficient Product Information

Your marketing and sales team should always be knowledgeable about the product that you are about to release into the market. Your sales team should also have the potential of looking for interested physicians for your product. For this to happen, adequate preparations must, therefore, be put in place. Furthermore, it would be best if you determined how your product will perform in the market to know the areas where to shift your focus. Having a vision of how your drug will perform in the market will also help you identify possible issues. In this way, you will have the best opportunity to handle them hence save you from unnecessary fears.

Startups in the pharmaceutical or biomedical fields need to study how entities like DarioHealth Corp. (NASDAQ: DRIO) execute product launches without breaking the bank.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, August 28th, 2020 Uncategorized Comments Off on $DRIO Mistakes to Avoid When Planning a Drug Launch

$WTER 420 with CNW – Cannabis Sales in California Rise Significantly as Lockdown Measures Remain in Place

During the last quarter, California raked in $208.4 million in tax revenue from cannabis. In comparison, this figure was slightly higher when compared with revenue from the first quarter of the year, the CDTFA reported last Wednesday.

Despite many industries declining in output or failing, the cannabis market seems to be operating at even greater efficiency, as the report from California shows.

The $208.4 million did not factor in tax revenue that was collected by each jurisdiction. In the first quarter of 2020, tax returns were $205.9 million, this is including the $26.9 million in cultivation tax, $107.4 million in cannabis excise tax as well as $71.6 million in sales tax.

Since retail sales for cannabis were put into effect, the state has amassed $1.45 billion in marijuana tax revenue. The figure is inclusive of sales, excise and cultivation taxes.

In line with a recent study, if bans on marijuana businesses were lifted, the revenue would increase. As for now though, 75% of counties and cities in the state still implement cannabis market bans. This is despite a statewide vote carried out in 2016 that legalized the plant for adult use.

While the California Department of Tax and Fee Administration analysis showed growth in revenue, the Legislative Analyst’s Office released a report on the same that cited a 7% decline in the same time period. However, they did not take into account sales tax and exclusively focused on cultivation and excise tax revenue. This accounts for the difference in the findings of the agencies.

The analyst who did the LAO report, Seth Kerstein, stated that they chose to omit data from sales tax citing problems with the accuracy of the methods used to acquire that data.

In Illinois, legal cannabis purchases are increasing steadily. The state of Illinois launched cannabis retail sales earlier this year in January. In July, it experienced an additional record-breaking month with recreational marijuana sales in the month adding up to an estimated $61 million. This number, was higher than the previous month’s record, which raked in a whooping amount of about $47 million.

Additionally, in Oregon, a similar trend in cannabis sales is being experienced by officials, in the middle of the global health pandemic. The data that was reported in May indicated that the adult-use cannabis sales had grown by a 60% margin.

Analysts say sector players like The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) will feel vindicated since the industry has always asserted that having a regulated marijuana market will open untold economic benefits for states.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Thursday, August 27th, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Cannabis Sales in California Rise Significantly as Lockdown Measures Remain in Place

$SGLB Announces Participation Schedule for September Investor Conferences

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, recently announced its plans to participate in investor conferences during the month of September 2020. According to the update, SGLB will participate in the LD 500 Virtual Investor Conference slated to take place from September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020. Sigma Labs CEO Mark K. Ruport will host a virtual presentation and participate in one-on-one meetings, and management will highlight its recent contract award with Mitsubishi Heavy Industries and other end users in a newly launched program.

To view the full press release, visit http://nnw.fm/4OjAJ

About Sigma Labs Inc.

Sigma Labs is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, August 27th, 2020 Uncategorized Comments Off on $SGLB Announces Participation Schedule for September Investor Conferences

$POAI and TumorGenesis Advancing Path Toward Patient-Specific Treatments

Predictive Oncology (NASDAQ: POAI), together with its TumorGenesis subsidiary, has achieved significant breakthroughs in applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Earlier in June, TumorGenesis, which is developing a new rapid approach to growing tumors in the laboratory, sold its first order of unique ovarian cancer cell culture media to a New England-based university carrying out research within the sector (http://ibn.fm/lpsCk). A recent article discussing POAI and TumorGenesis reads, “Predictive Oncology focuses on building AI-driven predictive models of tumor drug response and outcomes from its database of drug-response and genomic profiles gathered from more than 150,000 cancer cases. The company’s wholly owned TumorGenesis subsidiary specializes in the field of ovarian cancer, creating laboratory-grown cancer cells to be used in assisting researchers and clinicians identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they feed into TumorGenesis’ proprietary Oncology Capture Technology Platform, which isolates and helps categorize an individual patient’s heterogeneous tumor sample to enable the development of a patient-specific treatment plan (http://ibn.fm/lpsCk).”

To view the full article, visit: http://ibn.fm/2fWmR

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, August 27th, 2020 Uncategorized Comments Off on $POAI and TumorGenesis Advancing Path Toward Patient-Specific Treatments

$GNPX Pandemic Warning Signs We Missed

You never knew that there would be a pandemic, and you had never seen anything like this before. No one would ever have imagined a thing like this will strike. However, before COVID-19 hit the world, several people had already issued warnings about the pandemic. Those people included medical experts, famous authors, and presidents. These people were issuing warnings in conferences, televisions, and government reports. Here are some of the seven warning signs about the pandemic that we ignored:

UNC Specialists warned about the emergence of coronavirus (2015-2016)

A famous coronavirus epidemiologist at the University of North Carolina had been warning about the outbreak for several years. In a remarkable article termed as the Nature Medicine, the epidemiologist predicted a possible risk of SARS-COV re-emergence from the viruses circulating in the population of bats. In 2016 in a paper known as PNAS, he further warned that the virus outbreak was on the loose and showed potentialities that could greatly affect human beings.

TED Talk by Bill Gates “We are not ready” (2015)

Bill Gates delivered a TED talk in 2015 with the title “The next outbreak? We are not ready.” Gates said that the greatest risk of a global pandemic that is highly infectious was nearing. Gates reminded the world about the warning a year and eight months later in a World Economic Forum in Switzerland. In 2017 (October), at the American Society of Human Genetics conference, Bill Gates also mentioned the emergence of a deadly pandemic while addressing the members.

Bill Gates also talked about the need to come up with new mechanisms to help fight the pandemic. He spoke about the need to develop vaccines and other therapies quickly and further offered new vaccine development ideas using the adenovirus-associated DNA and RNA or even editing genes.

Fauci’s Speech at Georgetown (January, 2017)

Antony Fauci gave a public lecture at Georgetown University with the heading “Pandemic Preparedness in the Next Administration.” The main message in his speech was that there would be a big challenge in handling the pandemic. Fauci also added that the upcoming regimes would have the same challenges previous administrations had.

“Coming of the Next Plague” by the Atlantic

A catching story was written by a proper scientist for the Atlantic in 2018 about “The coming of the next plague: is the US prepared?” Ed Yong, the author at Atlantic, referred to the H1N1 flu that attacked Mexico and caught the U.S. by surprise. Yong talked of the H1N1, which had spread for months and had not been noticed in the U.S. Yong added that the White House had become a home to a conspiracy-minded president, which was not to be underestimated.

Remarks by Alex Azar DHHS secretary (April, 2019)

In 2019 at the Biodefense summit, Azar asked,” What keeps you awake in the biodefense world?” and the response was the Pandemic flu. He concluded by saying, “I think everybody in this summit shares the same concern.”

China Cases Detected by NCMI (November, 2019)

In November 2019, a confidential report was circulated by the National Center for Medical Intelligence that warned of a contagious disease in Wuhan, China. The report was issued to the National Security Council, White House, and to Mark Esper, the Defense Secretary, who denied its awareness.

Pandemic warnings in FEMA reports (2019)

In an event managed within the National Threat and Hazard Identification and Risk Assessment report, the Federal Emergency Management Agency had predicted that a new virus pandemic having no vaccine would lead to inadequate medical supply, strain health centers, and cause economic shutdowns.

Had these warnings been heeded, who knows how better prepared the world might have been before COVID-19 struck? It would be eye-opening to hear what biomed companies like Genprex Inc. (NASDAQ: GNPX) think about the usefulness of such early warnings.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, August 27th, 2020 Uncategorized Comments Off on $GNPX Pandemic Warning Signs We Missed

$POAI Artificial Intelligence Could Help Eradicate COVID-19

The use of artificial intelligence (“AI”) has increased over the years. This has enabled researchers to have the computing powers of higher orders than what was there when COVID-19 first struck. Today, artificial intelligence has significantly been used to find different patterns within large information sets. Furthermore, artificial intelligence is instrumental in helping you to understand better any information that is not characterized. AI can also be used in predicting trends and patterns of the various phenomenon, and this could hold the key to finding a solution to COVID-19.

Incorporating Artificial Intelligence in COVID-19 research

Artificial intelligence works even better with a set of information that has been well characterized. It will help you in picking up trends and patterns, especially when dealing with well-organized sets of data. One laboratory has been using AI in building dynamic, physics-based protein models. The models are to help come up with molecules that can help eradicate COVID-19 viruses as they interact with cells. Additionally, chemistry studies are also capable of generating information that can be used with the AI that can create a tight loop between computing and experimental work

Researchers can, therefore, use artificial intelligence to peruse through thousands of possible therapies in-store to come up with something novel to fight the virus. Both the physics and chemistry methods can be used with Artificial Intelligence to come up with a concrete and complete solution. Benevolent Artificial Intelligence recently identified “baricitinib,” an arthritis drug, as a possible therapy for COVID-19. The drug is in a phase three trial and its results are yet to be received. The process of using an already approved drug, such as baricitinib, was for the procedure to be faster and straight forward to find a drug that could quickly fight the pandemic.

How AI will spur baricitinib as a potential remedy for COVID-19

Baricitinib has the potential to deal with coronavirus in two ways: it may stop some of the kinases that the virus is using to gain access into the human cells, and it may also help in moistening the immune system overreactions as it has been in severe COVID-19 cases. In a nutshell, this drug has both the anti-inflammatory and antiviral combination in it.

Benevolent Artificial Intelligence also revealed that the movement of baricitinib within the kidney and liver showed that it could be combined with other antivirals, such as Remdevisir, without causing adverse effect to those organs. Such bulk information and research could not be possible without the help of artificial intelligence, according to one researcher.

Use of AI to generate lead compounds

Some companies are also aiming to use artificial intelligence in creating a purpose-built molecule to fight COVID-19, and the process has already shown some success. AI can also be employed in every step of drug discovery, development and in the demographic analysis that can be used to track COVID-19. The company has used the structure of the virus obtained from the SARS outbreak in 2003 to begin its drug finding process. All this progress has been due to the use of AI, which is now looked at as a potent tool in this fight. It wouldn’t be surprising if other biomed companies, such as Predictive Oncology (NASDAQ: POAI), are already using AI in their own operations.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $POAI Artificial Intelligence Could Help Eradicate COVID-19

$POAI Exclusive Resources Provide Personal Profiling, Tools to Improve Patient Outcomes

  • POAI, Helomics builds AI-driven models that predict drug response, patient outcome
  • Company tests patient tumor, generates comprehensive picture that oncologists use to individualize therapy
  • Key to individualized insight is POAI’s Tumor Drug Response Profiling (“TDRP”) platform, NGS-based genomic profiling, unmatched cancer knowledge base

Guided by the mantra that “cancer is personal — we believe therapy should be too,” Predictive Oncology (NASDAQ: POAI) subsidiary Helomics focus on building AI-driven models that will predict drug response and patient outcome of individual tumors. With the largest tumor inventory in the world, POAI leads the way in providing a functional precision medicine approach that harnesses the power of an individual patient’s tumor to personalize their cancer treatment plan.

POAI works closely with oncologists to provide key information to help improve their patients’ odds in their fight against cancer. Helomics current clinical test platform offers a powerful, proprietary approach that tests a patient’s unique tumor, then combines drug-response profiling and genomic profiling of that tumor to generate a comprehensive picture that an oncologist can use to individualize therapy and improve positive outcomes.

Oncologists rely on these personalized profiles to help reduce the risk that a patient receives ineffective therapies as well as to identify alternatives when a typical treatment recommended for certain types of cancer cannot be tolerated.

A key component in Predictive Oncology’s ability to offer such individualized insight is the company’s Tumor Drug Response Profiling (“TDRP”) platform, which it combines with the latest NGS-based genomic profiling and POAI’s vast cancer knowledge-base of 150,000 tumors. Exclusive to POAI, these resources provide a more functional approach to precision medicine and allow an oncologist to reach beyond genomics alone in providing cancer-treatment recommendations.

In addition, every tumor tested by POAI and Helomics adds data to the company’s unparalleled D-CHIP knowledgebase, which contains anonymized molecular and drug-response profiles from more than 150,000 cancer cases. This invaluable information provides researchers in pharma, biopharma and diagnostic companies actionable insights to help discover better targeted therapies as well as contribute to key developments in clinical trials, companion diagnostics, and biomarkers.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through the company’s Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy. In addition, the company is utilizing artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow

For more information about the company, visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $POAI Exclusive Resources Provide Personal Profiling, Tools to Improve Patient Outcomes

$SGLB to Present at Upcoming September Investor Conferences

SANTA FE, NM / August 26, 2020 / Sigma Labs, Inc. (“Sigma Labs” or the “Company”) (NASDAQ:SGLB), a leading developer of quality assurance software for the additive manufacturing industry, will participate in the following investor conferences during the month of September 2020: the LD 500 Virtual Investor Conference on September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020.

Sigma Labs CEO Mark K. Ruport is scheduled to host a virtual presentation during the conference and will also participate in one-on-one meetings throughout the day. Management will highlight its recent contract award with Mitsubishi Heavy Industries and other end users in the company’s newly launched @Sigma RTE program.

LD 500 Virtual Investor Conference
Date: Thursday, September 3, 2020
Time: 2:40 p.m. Eastern time (11:40 a.m. Pacific time) – Track 2
Webcast: https://www.webcaster4.com/Webcast/Page/2019/36829
Location: Virtual

H.C. Wainwright 22nd Annual Global Investment Conference
Date: Wednesday, September 16, 2020
Time: 4:00 p.m. Eastern time (1:00 p.m. Pacific time)
Webcast: https://ir.sigmalabsinc.com/news-events/ir-calendar
Location: Virtual

For more information or to schedule a one-on-one meeting with Sigma Labs management, please contact your conference representative or you may also email your request to SGLB@mzgroup.us or call Chris Tyson at (949) 491-8235.

About Sigma Labs

Sigma Labs Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D® brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D® for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.sigmalabsinc.com.

Investor Contact:
Chris Tyson
Managing Director
MZ Group – MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us

Company Contact:
Steven Gersten
Sigma Internal IR
813-334-9745
investors@sigmalabsinc.com

Wednesday, August 26th, 2020 Uncategorized Comments Off on $SGLB to Present at Upcoming September Investor Conferences

$GNPX Invited to Present at Prestigious LD 500 Virtual Investor Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it joins the lineup of presenters at this year’s LD 500 Virtual Investor Conference. The annual LD Conference spotlights some of the most prominent companies in the micro-cap world, and also includes interviews and keynotes with small-cap leaders. GNPX chairman and CEO Rodney Varner will provde a company overview as well as updates on Genprex’s lead drug candidate, GPX-001, which recently received fast track designation from the U.S. Food and Drug Administration for use in combination with AstraZeneca’s Tagrisso(R) for treatment of late-stage lung cancer with EGFR mutations; the presentation will also include a summary of the company’s preclinical diabetes gene-therapy candidate designed to treat, and perhaps cure, type 1 and type 2 diabetes. Held online for the first time, the elite conference is scheduled for Sept. 1–4; Chalmers’s presentation is slated for 2 p.m. EST on Tuesday, Sept. 1. More information, including how to register, is available at https://ld500.ldmicro.com.

To view the full press release, visit http://ibn.fm/ZMAeb

About Genprex Inc.

Genprex is a clinical-stage, gene-therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes that currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “GPX-001” (“quaratusugene ozeplasmid”), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). GPX-001 has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. GPX-001 has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with “EFGR” mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $GNPX Invited to Present at Prestigious LD 500 Virtual Investor Conference

$NETE What Many Don’t Know About Electric Vehicles

You may not have considered buying an electric car probably because you lack enough information about them. Furthermore, several myths and misconceptions have been spread around, and these may have made you shy away from these vehicles. However, here are some of the facts that you did not know about electric cars. Having a glance at this article will enhance your knowledge about electric vehicles:

Electric vehicles may be more expensive to buy than diesel and gas cars, but you will realize that they are cost-effective in terms of maintenance and eliminating the cost of fuel. Furthermore, electric vehicles are exempted from some taxes, and you will be given some incentive packages. What makes electric cars to be expensive is the cost of their batteries. However, their battery cost has drastically reduced, making these cars cost-effective for you. Surveys have also shown that in the next ten years, the price of electric vehicles will significantly drop even further.

Various models of electric cars are expected to rock the market every year. You will therefore have a variety of models to choose from. Furthermore, the number of the electric vehicles going to flock the roads in the next five years is huge as other sixty new models are about to be released on the market. Besides, they are also going to have spectacular speeds with some models cruising up to 300mph.

Your desire is always to have a quality car at a friendly price. It is the reason why most electric car dealers are offering you financial incentives for you to go for these cars. For instance, in the U.S., the government will provide you with some tax incentives when you purchase one of these cars. Additionally, the entire Europe is also offering you appealing incentives when you buy an electric vehicle. Most of the countries are offering these incentives as a strategy to promote environmental conservation since these cars do not emit greenhouse gases into the atmosphere.

You will no longer have the stress of branching to a charging station to charge your car because it is now easier to charge your vehicle at your home or your workplace. In the U.S., you can install a level 2 charging station at your home while in Europe you can have a 1-3 phase depending on the size of your residence. You can also do the same installation at your place of work. By doing this, you will only be making stopovers for snacks but not charging your car.

You may decide to use your electric car battery to power your home. By connecting it to your solar panels, you will have enough power which you can use in your house and also at your charging station. Your car will be helping in transporting you and at the same time helping you to generate energy at your residence.

You now know some of the fascinating facts about electric cars that you did not know before. It is now essential you consider owning one as it will be beneficial to you. It is no wonder that sustainable companies like Net Element (NASDAQ: NETE) are willing to work with electric vehicle companies since they share a desire to conserve the environment.

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $NETE What Many Don’t Know About Electric Vehicles

$WRTC Expands Domestic Footprint as More Agencies Outfit Frontline Officers

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its receipt of the first purchase orders for BolaWrap products and accessories from agencies in the states of Nevada and Arkansas. According to the update, the company has received initial and repeat purchase orders from law enforcement agencies across 13 states since the beginning of July. As a result, the company has provided BolaWrap devices to more than 215 agencies across 44 states. “We are very encouraged by the expansion of our domestic presence and our improving market position as more agencies across the United States continue to adopt the BolaWrap,” said Tom Smith, president of Wrap Technologies, in the press release. “The progression is similar to what I personally witnessed as the law enforcement community adopted the TASER. Initially, agencies attend demonstrations of a new product. Then, they are trained with the device and purchase products for field testing before ultimately outfitting their entire agency. It’s exciting to see a growing flow of initial and repeat orders placed by agencies for the BolaWrap as they move towards outfitting their frontline officers.”

To view the full press release, visit http://nnw.fm/qat7G

About Wrap Technologies, Inc.

Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury by agencies in cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth and Oak Ridge. For information about the company, please visit www.WrapTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $WRTC Expands Domestic Footprint as More Agencies Outfit Frontline Officers

$DRIO Ethical Considerations in Human Biospecimen Collection

As researchers are frantically looking for a COVID-19 vaccine and other treatments, safety, and health ethical issues of patients must be highly considered. Some ethical issues, like the anonymity of patients, must be handled with proper attention so as not to affect the esteem of any individual. As a researcher, before using any patient in your clinical trials, you must first obtain written consent from them. You may risk your job in acquiring the biospecimen from patients if you do not seek permission from them.

Also, you should familiarize yourself with your country’s legal and ethical laws regarding human subjects. For instance, several states have different bodies that give consent to research involving human subjects. However, it is always essential to remain professional and uphold high standards in every discipline that you are involved in.

Types of Specimen Researchers Collect

Potential samples that you may receive are excess materials from a process that your subject is already undertaking. In several countries, for you to obtain human biospecimen, you first need to get the donor’s consent. The remaining samples after the test have been conducted are not recollected for research again. However, other regulations that govern the re-use of these samples in a study must also be adhered to.

In the U.S., samples from corpses are not considered as human research; hence they can be exempted from the ethical issues regarding human subjects. In Europe, the samples from post-mortems are regarded as gifts, and if you have to use them in research, the ethical issues regarding human specimen must be strictly followed. In the UK, using samples from the deceased will require you as a researcher to seek informed consent from their next of kin and the samples to be used must also be stored at the Human Tissue Authority licensed headquarters.

Quality of Samples

Initially, biobanks were used as storage of the specimen for in-house studies. Since most of the researchers are putting their focus on personalized medicine, researchers require high-quality informatics specimen. Due to the differences in the specimen collection and storage methods, various researchers are focusing on standards to ensure they have quality and reliable samples.

Organizations, such as the International Society for Biological and Environmental Repositories, were established to focus on harmonizing and identifying quality standards. The body also ensures the researchers are well informed on the ethical issues and innovation by offering them some education.

Quantity of Samples

All research requires a large number of samples. Furthermore, the quantity should not affect their quality. The samples should also be of different varieties that match the situation under study. Besides, researchers also need to use demographics and clinical information to help support their research. The reliability of information obtained from human samples will depend on the consistency and quality to be analyzed.

Established biomedical companies like DarioHealth Corp. (NASDAQ: DRIO) have mastered all the research standards applicable in the U.S., and startups in this space need to borrow a leaf from these companies if they are to stay out of trouble.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $DRIO Ethical Considerations in Human Biospecimen Collection

$DRIO Positioned to Compete in ‘Largely Untapped US Market’

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, recently completed a round of successful fundraising that will assist in expanding the availability of its platform. DarioHealth secured approximately $28.6 million in aggregate gross proceeds from health-care funds and institutions across the United States and Israel through the private-placement transaction with accredited investors. The new capital coupled with existing cash  puts the company in its best financial state since its inception (http://ibn.fm/uKWvc). A recent article discussing this quotes Dario CEO Erez Raphael, who stated, “We are pleased to have the confidence of our largest shareholder and several new highly regarded health-care investors as we expand commercial to manage existing and anticipated near-term agreements with health-care payers. The adoption rate of digital therapeutics has been accelerated by the current pandemic. Dario’s efficacious, value-oriented solution is well-positioned to compete in this largely untapped U.S. market.”

To view the full article, visit: http://ibn.fm/vtGXU

About DarioHealth Corp.

DarioHealth is a leading, global, digital-therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. The company’s cross-functional team operates at the intersection of life science, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario offers one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new geographic markets to address chronic conditions using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, visit  www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $DRIO Positioned to Compete in ‘Largely Untapped US Market’

$WTER Products Available Through Largest US Food Redistribution Company

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) has announced that its products will be carried by Dot Foods Inc., the largest food redistribution company in the United States. This entry into the hospitality space includes the company’s Alkaline88(R) and A88 Infused(TM) lines as well as its aluminum bottles. A producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products, WTER said these products will be available nationwide to Dot Foods’ 4,300 customers around the country by Sept. 21, 2020. “Adding the largest food-service redistributor, Dot Foods, to our growing list of channel partners is another milestone for the company,” said Alkaline Water Company president and CEO Richard Wright in the press release. “Every year, Dot Foods sells millions of cases of beverages to its customers. This relationship will give us an entry into the hospitality industry, which we view as a significant opportunity for our growing lifestyle brands. There are over 600,000 restaurants and foodservice establishments that will now have access to our full line of products.”

To view the full press release, visit http://cnw.fm/Ea73g

About The Alkaline Water Company Inc.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $WTER Products Available Through Largest US Food Redistribution Company

$UUUU CEO to Present Company Update at LD 500 Conference

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, has announced that CEO Mark S. Chalmers has been invited to be a presenter at this year’s virtual LD 500 investor conference. During his presentation, Chalmers will provide an update on the company. The presentation will include an overview of UUUU’s critical mineral initiatives, including uranium production; it will also include discussion on the company’s strategic plan to eliminate debt and its progress with the rare earth element (“REE”) processing program. The prestigious conference is scheduled for Sept. 1–4; Chalmers’s presentation is slated for 4 p.m. EST on Wednesday, Sept. 2. More information, including how to register, is available at https://ld500.ldmicro.com. “We have been waiting for this moment all year long,” said LD founder Chris Lahiji in the press release. “Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space.”

To view the full press release, visit http://ibn.fm/DW3UE

About Energy Fuels Inc.

Energy Fuels is the leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers — the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill, the only conventional uranium mill operating in the United States today, has a licensed capacity of more than 8 million pounds of U3O8 per year and the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium-resource portfolios in the country, with several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Wednesday, August 26th, 2020 Uncategorized Comments Off on $UUUU CEO to Present Company Update at LD 500 Conference

$NETE Mullen Technologies Inc. to Attend Raymond James 2020 Virtual Diversified Industrials Conference

Mullen Technologies, a southern-California based, licensed electric vehicle (“EV”) manufacturer with international distribution that operates in various verticals of the automotive industry, which previously announced a definitive agreement to merge with Net Element (NASDAQ: NETE), announced that it will attend the Raymond James 2020 Virtual Diversified Industrials Conference today, August 25, 2020. Interested parties may access the presentation, which will also be available on Mullen’s website, by visiting the following link at 4 p.m. EST: http://ibn.fm/vTt43.

To view the full press release, visit http://ibn.fm/HQomd

About Mullen Technologies

Based in Southern California, Mullen Technologies is a licensed vehicle manufacturer focused on providing exciting electric vehicles that fit perfectly into the American consumer’s life by working independently as well as through strategic OEM partnerships. Mullen Technologies owns a number of synergistic businesses including: Mullen Auto Sales, a fast-growing series of pre-owned auto dealerships through California, CarHub, a new and unique digital platform that leverages AI to offer an interactive solution for buying, selling and owning a car, Mullen Energy, a division solely focused on advancing battery technology and emergency point-of-care solutions, and Mullen Finance Corp., a captive finance arm for consumer vehicle leases and loans.

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Tuesday, August 25th, 2020 Uncategorized Comments Off on $NETE Mullen Technologies Inc. to Attend Raymond James 2020 Virtual Diversified Industrials Conference

$UUUU Energy Fuels to Present at The LD 500 Conference

LAKEWOOD, COAug. 25, 2020Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (“Energy Fuels” or the “Company”), the leading uranium producer in the United States, is pleased to announce that CEO Mark S. Chalmers will be presenting at The LD 500 investor conference on Wednesday, September 2, 2020 at 4:00 PM (EST).

Mr. Chalmers will provide investors with an update on the Company’s various critical mineral initiatives, including uranium production, uranium and vanadium inventories, potential U.S. government action to support U.S. uranium miners, elimination of debt, and progress on the Company’s rare earth element (“REE”) processing program.

Register Here:  https://ld500.ldmicro.com/

Chris Lahiji, Founder of LD stated: “We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space.”

The LD 500 will take place on September 1st through the 4th.

View Energy Fuels’ LD profile here:  http://www.ldmicro.com/profile/uuuu 

About Energy Fuels: Energy Fuels is the leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The Company also produces vanadium from certain of its projects, as market conditions warrant, and it is evaluating the potential to produce rare earth elements. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers – the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the Company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” Energy Fuels’ website is www.energyfuels.com.

About LD Micro: Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

Cautionary Note Regarding Forward-Looking Statements: This news release contains certain “Forward-Looking Information” and “Forward-Looking Statements” within the meaning of applicable United States and Canadian securities legislation, which may include, but are not limited to, statements with respect to any expectations regarding: uranium production, uranium and vanadium inventories, potential U.S. government action to support U.S. uranium miners, the elimination of debt, and progress on rare earth elementsGenerally, these forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects,” “does not expect,” “is expected,” “is likely,” “budgets,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates,” “does not anticipate,” or “believes,” or variations of such words and phrases, or state that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “occur,” “be achieved” or “have the potential to.” All statements herein, other than statements of historical fact, are considered to be forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance of or achievements of the Company to be materially different from any future results, performance, or achievements, express or implied, by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements include risks associated with: any expectations regarding uranium production, uranium and vanadium inventories, potential U.S. government action to support U.S. uranium miners, the elimination of debt, and progress on rare earth elements; and the other factors described under the caption “Risk Factors” in the Company’s most recently filed Annual Report on Form 10-K, which is available for review on EDGAR at www.sec.gov/edgar.shtml, on SEDAR at www.sedar.com, and on the Company’s website at www.energyfuels.com. Forward-looking statements contained herein are made as of the date of this news release, and the Company disclaims, other than as required by law, any obligation to update any forward-looking statements whether as a result of new information, results, future events, circumstances, or as a result of changes in management’s estimates or opinions, or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements. The Company assumes no obligation to update the information in this communication, except as otherwise required by law.

Tuesday, August 25th, 2020 Uncategorized Comments Off on $UUUU Energy Fuels to Present at The LD 500 Conference

$SRAX BIG Seasons Makes It ‘Easier than Ever’ for Consumers to Own Data, Gain Compensation

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology products, recently launched BIG Seasons – a new payment system for the millions of subscribers on its BIGtoken platform (http://nnw.fm/AMOCN). Officially launched on July 1 in the U.S., UK, Canada, Australia, New Zealand and South Africa, each BIG Season is set to run for three months, during which time platform subscribers are able to earn points by engaging in a myriad of different activities. A recent article discussing this reads, “By earning points, BIGtoken users are able to raise their tiering within the application. Platform subscribers will enjoy further benefits as they see their point tiers rise through the five available levels, beginning as a ‘Starter’ all the way through to gaining the coveted ‘Influencer’ rank. With all payments being made within 15 days following the conclusion of each season, BIGtoken has made it easier than ever for consumers to own and manage access to their data while gaining compensation in return.”

To view the full article, visit: http://nnw.fm/7nlw4

About SRAX

SRAX is a digital-marketing and consumer data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends, and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Tuesday, August 25th, 2020 Uncategorized Comments Off on $SRAX BIG Seasons Makes It ‘Easier than Ever’ for Consumers to Own Data, Gain Compensation